← Back
$CTNM All transactions

Contineum Therapeutics, Inc.

A

$ Value

$0

Shares

26,000

Price

$0

Filed

Apr 28

Insider

Name

Watkins Tim

Title

CMO & Head of Development

CIK

0002065965

Roles

Officer

Transaction Details

Transaction Date

2025-04-28

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

26,000

Footnotes

Options granted outside of the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the inducement grant exception under Nasdaq Marketplace Rule 5635(c)(4). One-half of the option shares vest on October 28, 2025, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service. | Options granted outside of the Plan, pursuant to the inducement grant exception under Nasdaq Marketplace Rule 5635(c)(4). This grant is subject to a performance-based vesting condition to be satisfied upon the achievement of a particular clinical milestone, based on such performance condition being satisfied within two years of the grant date and subject to the Reporting Person's continuous service.

Filing Info

Accession No.

0001437749-25-013340

Form Type

4

Issuer CIK

0001855175

Watkins Tim's History

Date Ticker Type Value
2025-12-29 CTNM M $16K
2025-12-29 CTNM $44K
2025-12-29 CTNM M $0
2025-04-28 CTNM A $0
2025-04-28 CTNM A $0

Other Insiders at CTNM (90d)

Insider Bought Sold Last
Lorrain Daniel S.
Chief Scientific Officer
$56K 2026-04-06